A bill to require a report on foreign investment in the pharmaceutical industry of the United States.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senior Senator for Massachusetts. Democrat.
Last Updated: Jul 2, 2020
Length: 4 pages
116th Congress (2019–2021)
This bill was introduced on July 2, 2020, in a previous session of Congress, but it did not receive a vote.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
1 Cosponsor (1 Republican)
Jul 2, 2020
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Apr 26, 2021
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 1367.
S. 4191 (116th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 4191. This is the one from the 116th Congress.
This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2021). S. 4191 — 116th Congress: United States Pharmaceutical Supply Chain Review Act. Retrieved from https://www.govtrack.us/congress/bills/116/s4191
“S. 4191 — 116th Congress: United States Pharmaceutical Supply Chain Review Act.” www.GovTrack.us. 2020. October 25, 2021 <https://www.govtrack.us/congress/bills/116/s4191>
United States Pharmaceutical Supply Chain Review Act, S. 4191, 116th Cong. (2020).
|title=S. 4191 (116th)
|accessdate=October 25, 2021
|author=116th Congress (2020)
|date=July 2, 2020
|quote=United States Pharmaceutical Supply Chain Review Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.